Epidemiology of staphylococcal scalded skin syndrome in the United States: A cross-sectional study,
2010-2014
To the Editor: Staphylococcal scalded skin syndrome (SSSS) is a potentially fatal, superficial blistering disorder caused by infection with exfoliative toxin-producing strains of Staphylococcus aureus. Previous research examining the epidemiology of SSSS has been limited by small sample sizes or confined to populations abroad. [1] [2] [3] To better characterize the epidemiology of SSSS in the United States, we generated national hospitalization estimates for SSSS using the 2010-2014 National Inpatient Samples, which are resources sponsored by the Healthcare Cost and Utilization Project of the Agency for Healthcare Research and Quality. 4 
Fig 1.
Alopecia areata patient 1 before (A) and after 4 months (B) and 6 months (C) of treatment with tofacitinib 2% ointment. Ointment was applied only to the right half of the scalp for the first 2 months, at which time hair regrowth was evident only in the area of drug application. Subsequently, ointment was applied to the entire scalp. At month 4, there was more hair on the right scalp than on the left scalp. By month 6, hair growth was prominent on both sides. Table I ). The cumulative incidence of SSSS was 7.50 (95% CI 6.78-8.27) per 100,000 population among infants \1 year old, 0.94 (95% CI 0.89-0.99) per 100,000 population among children 1-17 years old, and 0.11 (95% CI 0.10-0.13) per 100,000 population among adults, for an overall incidence of 0.39 (95% CI 0.37-0.41) per 100,000 population. During the study period, the overall incidence of SSSS increased by 47.1% (P trend \ .001). When analyzed by age group, the annual incidence increased by 81.0% (P trend \ .001) among children \1 year old and by 83.8% (P trend \ .001) among children 1-17 years old; however, the annual incidence decreased by 15.4% (P trend \ .001) among adults. In regards to race and ethnicity, the annual incidence of SSSS increased by 188% (P trend \ .001) among blacks and by 51.9% (P trend \ .001) among whites. Incidence data is depicted in Table II. In-hospital mortality from SSSS was 1.3% (95% CI 0.78%-2.1%) for all age categories, 0.31% (95% CI 0.01-0.9%) among patients #17 years old, and 4.3% (95% CI 2.5%-7.3%) among adults. This study might underestimate the incidence and overestimate mortality because patients treated for SSSS in an out-patient setting were absent from this analysis. The incidence calculated here (0.39 per 100,000 persons), though, is higher than previous estimates (0.009 to 0.056 cases per 100,000 persons), which have been limited by small sample sizes (14 cases) and methodological differences (inclusion of bullous impetigo in SSSS incidence calculations). 2, 3 Additional research is necessary to determine if exfoliative toxin-producing strains of S. aureus are becoming more common in certain communities, or if global warming is contributing to the rising incidence of SSSS, considering the condition occurs most often in the warmest months of the year. Socioeconomic and geographic barriers to dermatology care in urban and rural US populations To the Editor: Access to dermatology care is affected by socioeconomic status, rurality, and provider distribution. Patients in higher socioeconomic settings have preferential access and greater use of specialist services. 1 Less than 10% of dermatologists practice in rural areas; 40% practice in the 100 densest US areas. 1 This maldistribution may cause patients to postpone or forgo specialty care, leading to treatment delays and disease progression. Through examining associations between geographic and sociodemographic barriers to care, interventions can be developed to minimize provider maldistribution.
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